Latest News & Features
Asia
The Delhi High Court has issued a interim injunction stopping Indian generic drug maker Cipla from selling copies of Novartis’s respiratory drug Onbrez (indacaterol) in the country. 15 January 2015
Big Pharma
The Federal Court of Justice of Germany, the country’s highest court, has rejected an appeal from AstraZeneca in which the pharmaceutical company claimed that a patent used in its drug Seroquel XR (quetiapine) is valid. 14 January 2015
Americas
The US Court of Appeals for the Federal Circuit has affirmed a lower court’s decision that manufacturer W L Gore & Associates infringed a patent owned by medical device maker Bard Peripheral Vascular, bringing to an end a dispute that stems from more than 40 years ago. 14 January 2015
Europe
UK regulatory body the Medicines and Healthcare and Products Regulatory Agency has successfully taken down more than 1,600 websites, some of which were selling counterfeit drugs. 13 January 2015
Europe
Biopharmaceutical company Shire has agreed a multi-billion pound deal to buy US business NPS Pharmaceuticals, which operates in the same industry. 12 January 2015
Asia
Glenmark Pharmaceuticals has been handed victory after the Indian Patent Office reversed a ruling that had granted a patent to US company Abbott Biotechnology for its anti-arthritis drug Humira (adalimumab). 9 January 2015
Americas
Pharmaceutical companies Teva and Mylan have each been granted permission to market a generic version of Novartis’s blood pressure treatment Diovan (valsartan) in the US. 8 January 2015
Big Pharma
Police in the UK have charged a man after accusing him of selling counterfeit drugs including erectile dysfunction and abortion medicines online. 7 January 2015
Americas
The US Food and Drug Administration has recommended that an application by pharmaceutical company Novartis to market a biosimilar version of Amgen’s cancer drug Neupogen (filgrastim) be approved. 5 January 2015
Americas
US pharmaceutical company Strategic Science and Technologies has signed an option agreement with “one of the world’s largest over-the-counter healthcare companies” to commercialise one of its ibuprofen products. 22 December 2014